期刊文献+

蛋白激酶C-δ阻断剂Rottlerin对人结肠癌细胞的影响及其机理 被引量:3

The effect of PKC-S inhibitor Rottlerin on human colon cancer cell line SW1116 and its mechanism
原文传递
导出
摘要 目的研究蛋白激酶C-δ(PKC-δ)阻断剂Rottlerin对人结肠癌细胞的影响及其机理。方法培养人结肠癌细胞SW1116,以Rottlerin 10μmol/L干预24 h,并以DMSO为对照。以定量RT- PCR检测DNA甲基转移酶(DNA methyltransferase,Dnmt)1、3a、3b和抑癌基因APC、p21WAF1和p16INK4A基因转录水平;流式细胞仪分析细胞周期;光学显微镜下观察细胞形态学变化。结果PKC-δ阻断剂Rottlerin可抑制Dnmt1和Dnmt3a表达,上调APC、p21WAF1和p16INK4A转录;Rottlerin明显增加G0/G1期细胞百分比(P=0.02),显著降低G2/M期细胞百分比(P=0.01);Rottlerin可使细胞胞浆增加,体积增大,细胞变得肿胀,轮廓模糊,细胞核分裂相明显减少。结论PKC-δ阻断剂Rottlerin通过调控DNA甲基化水平以及阻断MAPK途径,抑制结肠癌SW1116细胞分裂、增殖。 Objective To evaluate the effect of PKC-δ inhibitor Rottlerin on human colon cancer cells and its mechanism. Methods Human colon cancer cell line SW1116 cells were treated with Rottlerin. The transcriptional level of DNA methyltransferase (Dnmt)1, Dnmt3a and Dnmt3b was detected by real-time RT-PCR. Cell cycle distribution was evaluated by flow cytometry (FCM). In addition, cellular morphological changes were examined by light microscopy. Results PKC-δ inhibitor decreased the expression of Dnmtl, Dnmt3a mRNA, up-regulated APC, p21^WAF1 and p16^INK4A mRNA. Demonstarted by flow cytometry, Rottlerin increased the percentage of cell cycle G0/G1 phase cell numbers ( P = 0.02 ) and decreased the percentage of cell cycle GJM phase cell numbers (P = 0.01 ). Remarkable changes of cellular morphology were observed under light microscope: The volume and cytoplasm of cells treated with Rottlerin were increased. The cell contour was not very clear, and mitotic figures were less frequently seen. Conclusion PKC-δ inhibitor Rottlerin inhibites cell division and proliferation of the colon cancer SW1116 cells through regulating DNA methylation and blocking the signaling pathway of mitogen-activated protein kinase ( MAPK).
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2006年第8期564-567,共4页 Chinese Journal of Oncology
基金 国家重点基础研究发展计划(973计划)资助项目(2005CB522408) 上海市重点学科建设资助项目(Y0205)
关键词 蛋白激酶C-δ阻断剂 ROTTLERIN 人结肠癌细胞 PKC-δ inhibitor Rottlerin Human colon cancer cells
  • 相关文献

参考文献10

  • 1Fang JY, Richardson BC. The extracellular signal regulated kinase-mitogen-activated protein kinases signaling pathway and human colorectal cancer. Lancet Oncology, 2005, 6 : 322-327.
  • 2Thors B, Halldorsson H, Clarke GD, et al. Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial ceils: differential role of protein kinase C.Atherosclerosis, 2003, 168:245-253.
  • 3Ryu MS, Lee MS, Hong JW, et al. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res,2004, 299: 159-170.
  • 4陈朝飞,房静远,孙丹凤,翁玉蓉,李恩灵,朱红音,顾伟齐.丝裂原激活蛋白激酶阻断剂与DNA甲基化酶抑制剂对人结肠癌细胞的协同影响[J].中华消化杂志,2006,26(2):87-91. 被引量:5
  • 5Dong C, Davis R J, Flarell RA. Map kinases in the immunere sponse. Annu Rev Immunol, 2002, 20: 55-72.
  • 6刘宁,孙黎光,于卉影,张颐,杨菁,王晓鹏.细胞外信号调节蛋白激酶在人胃癌细胞Fas介导的凋亡信号通路中的作用[J].中华肿瘤杂志,2005,27(4):201-203. 被引量:3
  • 7Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res, 1998, 74 : 49-139.
  • 8Pruitt K, Ulku AS, Frantz K, et al. RAS mediated loss of the proapoptotic response protein par-4 is mediated by DNA hypermethylation through RAF-independent and RAF-dependent signaling cascades in epithelial cells. J Biol Chem, 2005, 280:23363-23370.
  • 9Woods D, Parry D, Cherwinski H, et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21^Cipl. Mol Cell Biol, 1997, 17: 5598-5611.
  • 10Blagosklonny MV, Prabhu NS, El-Deity WS. Defects in p21^WAFI/CIPI, Rb and c-myc signaling in phorbol ester-resist antcancer cells. Cancer Res, 1997, 57:320-325.

二级参考文献20

  • 1Nagata S, Golstein P. The Fas death factor. Science, 1995,267:1449-1456.
  • 2Holmstrom TH, Chow SC, Elo I, et al. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J Immunol, 1998,160:2626-2636.
  • 3Shapiro PS, Ahn NG. Feedback regulation of Raf-1 and mitogen-activated protein (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1). J Biol Chem, 1998,273:1788-1793.
  • 4Bang YJ, Kwon JH, Kang SH, et al. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun. 1998,250:43-47.
  • 5Krammer PH. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol, 1999, 71:163-210.
  • 6Tran SE, Holmstrom TH, Ahonen M, et al. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem, 2001, 276:16484-16490.
  • 7Wajant H. The Fas signaling pathway: more than a paradigm. Science, 2002, 296:1635-1636.
  • 8Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest, 2002, 109:437-441.
  • 9Sakata K, Sakata A, Vela-Roch N, et al. Fas(CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes. Eur J Immunol, 1998, 28:2648-2660.
  • 10Fang JY.Lu R,Mikovits JA,et al.Recombinant DNA methyltransferase 1 constructs regulate expression of hMSH2 and hMLH1 in human colon cancer cell line SW1116.Cancer Lett,2005,225:45-51.

共引文献6

同被引文献13

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部